Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
2
Cambridge Enterprise, Parkwalk Advisors
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We provide next generation fluorescence, spectral, and mass cytometry services. Project design, wet lab assay development, and advanced…
Pioneering next generation therapeutics through cutting-edge research and AI-powered drug discovery.
PharmEnable combines medicinal chemistry expertise with machine learning to find drug candidates for challenging protein targets. Founded…
Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
Specialist Preclinical Drug Discovery CRO. Leaders in ion channel, cardiac safety and neuroscience screening.
We provide comprehensive, quantified, and flexible Target Safety Intelligence to assist toxicologists, informaticians, and drug discovery…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Cambridge EnterpriseVia a fund
Parkwalk AdvisorsVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Cambridge spin-off Zomp wins £2M backing from Zeiss Ventures-led group optics.org
Investment will help develop 3D imaging flow cytometer for "quantitative imaging of millions of cells".
Read more
Report
Shoe retailer Zomp to close after almost 50 years in business
Popular women's shoe retailer Zomp will close its doors in the coming weeks after almost 50 years in business.
Read more
Report